Swanhill Capital

Swanhill Capital is a venture capital firm dedicated to investing in healthcare companies, excluding biotechnology and pharmaceutical ventures. They focus on long-term capital appreciation and expanding their investment portfolio by participating as minority or majority investors in companies at all phases of their life cycle, from seed rounds to traditional leveraged buyouts.

The firm's investment strategy encompasses a broad spectrum of healthcare services, aiming to support companies that can build category power through defensible networks, platforms accelerated by third-party developers, or dynamic data feedback loops that enhance people's lives. They typically look for companies with annual recurring revenues of $100 million or more and high double-digit growth rates.

Swanhill Capital's approach is characterized by a commitment to understanding each company's unique situation and developing customized plans with strategies designed to achieve specific goals and objectives. Their team leverages years of client relationships and a highly credentialed staff to create diversified investment portfolios and individualized wealth plans, emphasizing capital preservation and independence in managing all asset classes and currencies.